Thierry Van Nieuwenhove

CEO

4 past transactions

Arcinova

Acquisition in 2021
Their innovative approach, agility and flexibility enables us to overcome project challenges and save our customers valuable time - enabling them to bring life-changing medicines to market more rapidly and cost-effectively.They work with big pharma, speciality pharma and biotech companies across the world, from established multinationals to emerging start-ups.

Pharmaterials

Acquisition in 2017
Pharmaterials, a Quotient Sciences business, is a science driven contract research organisation specialising in the optimisation of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials.

QS Pharma

Acquisition in 2017
Founded in 2002, QS Pharma specialises in the formulation development and manufacturing of small molecule drug products, and is capable of supporting customer programs through all stages of development and commercialisation. Of particular relevance is QS Pharma’s capability to work with high potency molecules, which is a fast-growing market need.

SeaView Research

Acquisition in 2017
SeaView Research is a clinical research organization providing quality clinical pharmacology testing and laboratory services to the pharmaceutical industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.